DENTSPLY SIRONA (NASDAQ:XRAY) Rating Lowered to Hold at StockNews.com

StockNews.com lowered shares of DENTSPLY SIRONA (NASDAQ:XRAY - Free Report) from a buy rating to a hold rating in a research note issued to investors on Friday morning.

A number of other analysts have also weighed in on XRAY. Needham & Company LLC lowered their target price on DENTSPLY SIRONA from $25.00 to $23.00 and set a "buy" rating for the company in a report on Friday. Jefferies Financial Group cut DENTSPLY SIRONA from a "buy" rating to a "hold" rating and decreased their price objective for the stock from $30.00 to $20.00 in a research note on Thursday, January 23rd. Mizuho assumed coverage on DENTSPLY SIRONA in a research note on Wednesday, December 4th. They issued a "neutral" rating and a $21.00 target price on the stock. Morgan Stanley decreased their price target on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating for the company in a research report on Tuesday, December 17th. Finally, Leerink Partnrs cut shares of DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a report on Thursday, November 7th. Eleven investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $23.58.

DENTSPLY SIRONA Stock Down 2.5 %

Shares of NASDAQ:XRAY traded down $0.40 during trading hours on Friday, hitting $15.59. The company's stock had a trading volume of 3,382,554 shares, compared to its average volume of 2,593,609. The firm's fifty day moving average price is $18.77 and its 200 day moving average price is $21.39. DENTSPLY SIRONA has a 52 week low of $15.47 and a 52 week high of $34.28. The company has a market capitalization of $3.10 billion, a price-to-earnings ratio of -7.53, a P/E/G ratio of 1.80 and a beta of 0.96. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 4.11%. DENTSPLY SIRONA's payout ratio is -14.07%.

Insider Transactions at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier bought 15,142 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The shares were purchased at an average cost of $16.51 per share, with a total value of $249,994.42. Following the transaction, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. The trade was a 22.66 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.52% of the company's stock.

Institutional Trading of DENTSPLY SIRONA

Several large investors have recently added to or reduced their stakes in XRAY. Riverview Trust Co purchased a new position in shares of DENTSPLY SIRONA in the fourth quarter worth about $26,000. Colonial Trust Co SC acquired a new position in DENTSPLY SIRONA in the 4th quarter worth approximately $26,000. Capital Performance Advisors LLP purchased a new position in DENTSPLY SIRONA during the 3rd quarter worth approximately $27,000. MassMutual Private Wealth & Trust FSB lifted its stake in DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock valued at $27,000 after acquiring an additional 1,232 shares during the period. Finally, UMB Bank n.a. boosted its holdings in shares of DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after acquiring an additional 564 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company's stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.